Lilly, Bayer dodge whistleblower suits as judge follows DOJ's lead
admin 2nd October 2019 Uncategorised 0Eli Lilly and Bayer are in the clear. A set of whistleblower lawsuits alleging drugmakers ran “white-coat marketing” schemes—by offering nursing and reimbursement services as kickbacks—generated buzz in the industry, but government prosecutors looked into the claims and opted not to move forward.
More: Lilly, Bayer dodge whistleblower suits as judge follows DOJ's lead
Source: fierce